Urology Guidewires Market size is anticipated to reach USD 825.72 million by 2030

 Urology Guidewires Industry Overview

The global urology guidewires market size was valued at USD 474.99 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.37% from 2022 to 2030.

The growth of the market is primarily driven by the increasing prevalence of urological disorders such as Urinary Tract Infections (UTIs), kidney and ureteral stones; the rising preference for minimally invasive surgeries; and the rising geriatric population in the Asia Pacific region, especially in countries such as Japan, India, and China.

The COVID-19 pandemic had a short-term impact on the urology guidewires market and is expected to create potential opportunities for market players during the forecast period. The short-term impact is due to the number factors such as the number of beds available for urological patients had to be reduced to devote beds and personnel to the new COVID-19 wards, there was a need to avoid infecting elective patients through hospital contamination, and the newly constituted COVID-19 ward, 30% of the remaining urology medical personnel became entirely dedicated to managing the infected patients.

Gather more insights about the market drivers, restrains and growth of the Global Urology Guidewires Market

According to the African Journal of Urology in 2021, all types of elective urological procedures have decreased significantly. In particular, ureteroscopic lithotripsy, percutaneous nephrolithotomy, transurethral resection of the prostate, urethroplasty, and renal transplant had the highest cut-down. For instance, according to early urologic recommendations issued in April 2021, from weeks 8–9 to weeks 11–13, the trend for 2020 urologic activity dropped steadily (Average weekly % age changes range -41 % to -29.9 %; p 0.001). Additionally, as per the same source mentioned above, one-third of uro-oncologic procedures may have been postponed. As a result, due to the outbreak of the COVID-19 pandemic in 2020, sales of urological guidewires dropped dramatically.

However, in phase 2 of the pandemic, the market is expected to grow and rebound over the forecast period. Most governments around the world have begun to ease lockdown restrictions and recommence some elective surgeries. Key players intend to expand their enterprises regionally, build new warehouses in new places, and run their operations through multiple channels in the worst-affected areas. For instance, in February 2020, Integer Holdings Corporation announced that it has finalized the acquisition of Inomec, establishing its presence in Israel. With the acquisition, Integer will be able to develop a regional R&D and sales center, as well as add critical catheter design, clinical, and pilot production skills to its extensive portfolio, enhancing its position as a preferred partner for new medical solutions. Additionally, rerouting logistics, sourcing from additional partners, and air freight delivery are among the strategies companies are employing to deal with supply chain interruptions. These characteristics are projected to generate lucrative market growth prospects.

The increasing prevalence of kidney stone disease, cystitis, benign prostatic hyperplasia, and other urinary tract disorders are expected to drive the urology guidewires market during the forecast period. According Journal of Taibah University Medical Sciences in 2021, kidney stones are one of the most excruciating urological conditions. It has recently become extremely common worldwide (7–13 % in North America, 5–9% in Europe, and 1–5% in Asia). Kidney stones also increase the risk of chronic kidney disease by 60% and end-stage renal disease by 40%, which is predicted to drive market expansion in the near future.

Over the past decade, the demand for Minimally Invasive Surgeries (MIS) is increasing. According to The Mount Sinai Hospital in 2021, novel diagnostic techniques and less invasive therapies for prostate, kidney, and bladder malignancies, as well as a wide range of urologic illnesses, are becoming more widely used. Furthermore, between 2019 and 2021, there was a 50% increase in the number of procedures for advanced bladder cancer, a 20% increase in procedure volume for the kidney cancer program, and a 34% increase in volume for the prostate cancer program, all of which are expected to boost the market growth in the near future.

Research results published by manufacturers (Ethicon Endo-Surgery, Inc.) suggest that minimally invasive surgeries are rapidly replacing invasive surgeries owing to the following factors such as higher patient satisfaction owing to lesser incision wounds, involve a relatively lesser number of hospital stays, and therefore are economically viable and involve a lesser number of postsurgical complications and lower mortality rates. Guidewires are used in minimally invasive procedures, thus the rising demand for minimally invasive surgeries is expected to boost the market during the forecast period.

Browse through Grand View Research's Medical Devices Industry Research Reports

  • Medical Crutches Market: The global medical crutches market size was valued at USD 727.4 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2023-2030.
  • Dental Compressors Market: The global dental compressors market size was valued at USD 360.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. 

Market Share Insights

  • February 2022: The U.S. Food and Drug Administration (FDA) has approved an expanded indication for Teleflex Incorporated's coronary guidewires and specialty catheters for use in crossing percutaneous coronary interventions, chronic total occlusion (PCI, CTO), which is expected to boost the market growth in the near future.
  • December 2021: Oscor, Inc., has been acquired by Integer Holdings Corporation, a medical device outsource (MDO) manufacturer. Integer's ability to serve clients is strengthened by the purchase of Oscor, which expands their product offering in neurostimulation leads, and cardiac and steerable sheaths, and adds low-cost production capacity to support expansion, which is likely to boost the market's growth in the near future.
  • February 2021: the acquisition of an Israeli medical equipment firm by Olympus Corporation has been completed. Olympus increases its business line by delivering in-office treatment for benign prostatic hyperplasia (BPH), which is expected to boost the market growth in the forthcoming years.

Key Companies Profile

Some prominent players in the global urology guidewires market include:

  • Boston Scientific Corporation
  • Integer Holdings Corporation
  • Advin Health Care
  • Cook Medical
  • Olympus America
  • Teleflex Incorporated
  • MEDpro Medical B.V.  
  • ACE Medical Devices& Others

Order a free sample PDF of Urology Guidewires Market Intelligence Study, published by Grand View Research. 

Comments

Popular posts from this blog

Global Potash Market: Trends, Growth & Forecast 2023-2032

Smart Ticketing Market Report: Emerging Technologies & Market Opportunities

Boosting Crop Yields: India Foliar Fertilizer Market Trends & Forecasts